Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH  
1.94
+0.34 (+21.25%)
7:59:46 PM EDT: $1.95 +0.01 (+0.52%)
Earnings Announcements

Cyclo Therapeutics Reports Third Quarter Results

Published: 11/11/2022 13:11 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements.
Revenue is expected to be $0.64 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.